Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age
Clinical trial NCT02979639 · COMPLETED
Trial details
- NCT number
- NCT02979639
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-16
- Primary completion
- 2017-04-12
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.